当前位置:
X-MOL 学术
›
Aliment. Pharm. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Editorial: identifying candidates for pegylated interferon add-on to entecavir therapy in patients with HBeAg-positive chronic hepatitis B.
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2019-03-01 , DOI: 10.1111/apt.15136 Cheng-Yuan Peng
中文翻译:
社论:确定HBeAg阳性慢性乙型肝炎患者使用恩替卡韦治疗的聚乙二醇化干扰素的候选药物。
更新日期:2019-11-01
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2019-03-01 , DOI: 10.1111/apt.15136 Cheng-Yuan Peng
中文翻译:
社论:确定HBeAg阳性慢性乙型肝炎患者使用恩替卡韦治疗的聚乙二醇化干扰素的候选药物。